Trial · NCT03615404
Adverse events44
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 44
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 4 | 9 | |
| other | Sinus tachycardia | Cardiac disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 2 | 9 | |
| other | Eye disorders - Other, specify | Eye disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Abdominal pain | Gastrointestinal disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Constipation | Gastrointestinal disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 2 | 9 | |
| other | Diarrhea | Gastrointestinal disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Hemorrhoids | Gastrointestinal disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Nausea | Gastrointestinal disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 3 | 9 | |
| other | Vomiting | Gastrointestinal disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 3 | 9 | |
| other | Chills | General disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Fatigue | General disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 4 | 9 | |
| other | Fever | General disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Injection site reaction | General disorders | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 2 | 9 | |
| other | Infections and infestations - Other, specify | Infections and infestations | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 2 | 9 | |
| other | Upper respiratory infection | Infections and infestations | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 2 | 9 | |
| other | Urinary tract infection | Infections and infestations | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Alanine aminotransferase increased | Investigations | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Alkaline phosphatase increased | Investigations | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 1 | 9 | |
| other | Aspartate aminotransferase increased | Investigations | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 2 | 9 | |
| other | Lymphocyte count decreased | Investigations | CMV-DCs With GM-CSF and Td (Tetanus Toxoid) | 8 | 9 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03615404/events